Dr. Atanu Bhattacharjee

Biotechnology & Bioinformatics Department

Designation: Assistant Professor

Qualifications:

M.Sc (Botany), M.Sc (Bioinformatics) & Ph.D 

Areas af Interest/Specialization:

Cardiovascular disease

Experience:  13 Years

Awards:

  • Awarded the DBT Overseas Associateship by DBT in 2012

Phd Awarded/Supervised:

01 (Awarded)

Research Projects

01

Publications

 (Selected List)

  • Arun Bahadur Gurung  and Atanu Bhattacharjee.  (2019). Met117 oxidation leads to enhanced flexibility of cardiovascular biomarker- lipoprotein- associated phospholipase A2 and reduced substrate binding affinity with platelet-activating factor. At: International conference on Advanced Chemical and Structural Biology. 19-21st February 2019 organised by: PRIST (Deemed to be University), Thanjavur , Tamil Nadu
  • Debabrata Dutta, Anirudha Dutta, Atanu Bhattacharjee, Amit Basak and Amit Kumar Das (2014).). Cloning, expression, crystallization and preliminary X-ray diffraction studies of staphylococcal superantigen-like protein1 (SSL1). Acta Cryst. (2014). F70, 600–603
  • P. Yadav , A. Chatterjee , A. Bhattacharjee. (2014). Identification of deleterious nsSNPs inα, μ, π and θ class of GST family and their influence on protein structure. Genomics Data 2 (2014) 66–72
  • Baphilinia Jones Mylliemngap, Angshuman Borthakur, Devadasan Velmurugan & Atanu Bhattacharjee (2012). Insilico analysis and molecular docking of resuscitation promoting factor B (RpfB) protein of Mycobacterium tuberculosis..Bioinformation. 8(14):646-651
  • Barh D, Jain N, Tiwari S, Parida BP, D'Afonseca V, Li L, Ali A, Santos AR, Guimarães LC, de Castro Soares S, Miyoshi A, Bhattacharjee A, Misra AN, Silva A, Kumar A, Azevedo V. [2011] A novel comparative genomics analysis for common drug and vaccine targets in Corynebacterium pseudotuberculosis and other CMN group of human pathogens. Chemical Biology & Drug Design; 78(1):73-84.  
  • Debmalya Barh, Shoaib Ahmad, Atanu Bhattacharjee (2010). NR2E1 inhibits cell proliferation in lung squamous cell carcinomas by regulating entry to cell cycle. Journal of Thoracic Oncology. 5(5): S46.
  • Gurung, A. B., Ali, M. A., Bhattacharjee, A., AbulFarah, M., Al-Hemaid, F., Abou-Tarboush, F. M., ... & Lee, J. (2016). Molecular docking of the anticancer bioactive compound proceraside with macromolecules involved in the cell cycle and DNA replication. Genet. Mol. Res15.
  • Islam, M. M., Gurung, A. B., Bhattacharjee, A., Aguan, K., & Mitra, S. (2016). Human serum albumin reduces the potency of acetylcholinesterase inhibitor based drugs for Alzheimer's disease. Chemico-biological interactions249, 1-9.
  • Gurung, A. B., Aguan, K., Mitra, S., & Bhattacharjee, A. (2016). Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer’s disease. Journal of Biomolecular Structure and Dynamics, 1-14.
  • Gurung, A. B., Ali, M. A., Bhattacharjee, A., Al-Anazi, K. M., Farah, M. A., Al-Hemaid, F. M., ... & Al-Anazi, F. S. M. (2016). Target fishing of glycopentalone using integrated inverse docking and reverse pharmacophore mapping approach. Genet Mol Res15, 01-13.
  • Gurung, A. B., Bhattacharjee, A., & Ali, M. A. (2016). Exploring the physicochemical profile and the binding patterns of selected novel anticancer Himalayan plant derived active compounds with macromolecular targets. Informatics in Medicine Unlocked5, 1-14.
  • Bora, B., Biswas, A. D., Gurung, A. B., Bhattacharjee, A., Mattaparthi, V. S. K., & Mukherjee, A. K. (2017). An in silico approach to understand the structure–function properties of a serine protease (Bacifrinase) from Bacillus cereus and experimental evidence to support the interaction of Bacifrinase with fibrinogen and thrombin. Journal of Biomolecular Structure and Dynamics35(3), 622-644.
  • Bhattacharjee, B., Pathaw, N., Chrungoo, N. K., & Bhattacharjee, A. (2017). Molecular modelling, dynamics simulation and characterization of antifungal chitinase from Sechium edule. Gene606, 39-46.
  • Gurung, A. B., & Bhattacharjee, A. (2017). Structure based virtual screening identifies Pranlukast as a potential inhibitor against Plasmodium falciparum Adenosine Deaminase enzyme. Gene Reports6, 54-66.

Book Chapters:

  • Velmurugan, D & H. V. Kutumbarao, N & Vijayan, Viswanathan & Bhattacharjee, Atanu. (2019). Structure-Based Drug Design with a Special Emphasis on Herbal Extracts. In book: Structural Bioinformatics: Applications in Preclinical Drug Discovery Process, Springer publication, pp.271-305
  • Ramakrishnan Chandrasekaran, Atanu Bhattacharjee, Devadasan VelmuruganAnti-inflammatory and Antidote Drug Discovery with Secreted Phospholipase A2 (2019). In book: Biocatalysis. Chandrasekaran R., Bhattacharjee A., Devadasan V. (2019) Anti-inflammatory and Antidote Drug Discovery with Secreted Phospholipase A2. In: Husain Q., Ullah M. (eds) Biocatalysis. Springer, Cham. pp 193-211

Papers presented in Conferencs/Seminars:

  • Arun Bahadur Gurung  and Atanu Bhattacharjee.  (2019). Met117 oxidation leads to enhanced flexibility of cardiovascular biomarker- lipoprotein- associated phospholipase A2 and reduced substrate binding affinity with platelet-activating factor. At: International conference on Advanced Chemical and Structural Biology. 19-21st February 2019 organised by: PRIST (Deemed to be University), Thanjavur , Tamil Nadu